EAG Laboratories

EAG Laboratories

EAG Laboratories

Date Founded



4780 Discovery Drive,Columbia, MO 65201

Type of Company


Employees (Worldwide)

1,001 - 5,000


Medical Support Services
Waste Management & Recycling
Other Business & Consulting Services

Company Description

EAG Laboratories provides product development and analytical testing services to the pharmaceutical, biotechnology, animal health, crop protection, consumer products, and chemical industries. It offers drug development, environmental testing, biotech crop development, and contract synthesis. The company was founded by Charles Gehrke in 1968 and is headquartered in Columbia, MO.

Contact Data
Trying to get in touch with decision makers at EAG Laboratories? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Vice President, Product Development Services

Vice President, Business Development

Vice President-Marketing & Communications

Group Leader

Senior Director of Product Management


Associate Director

Program Director

Benefit Plan Administrator

Vice President, Human Resources

Paths to EAG Laboratories
Potential Connections via
Relationship Science
EAG Laboratories
Recent Transactions
Details Hidden

Odyssey Investment Partners LLC, Evans Analytical Group LLC, Newstone Capital Partners LLC purchase EAG Laboratories from Celerity Partners, Inc.

Details Hidden

EAG Laboratories purchases Morse Laboratories LLC

Details Hidden

EAG Laboratories raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onOdyssey Investment Partners LLC, Evans Analytical Group LLC, Newstone Capital Partners LLC purchase EAG Laboratories from Celerity Partners, Inc.

Advisors & Consultants
Legal Advisor

Managing Partner at Foley & Lardner LLP

Scientific Advisor

Former Vice President, Operations at Gene Express, Inc.

Scientific Advisor
Details Hidden

Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO.

Details Hidden

Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The firm involves in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. Its product candidate GC4419 reduces severe oral mucositis in patients with head and neck cancer undergoing radiation therapy and also receiving cisplatin, a chemotherapy drug. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.

Details Hidden

Celerity Partners seeks investment opportunities locates in US and Canada. The firm targets companies operating in the fields of healthcare services, contract manufacturing, energy services, infrastructure and environmental sciences, transportation logistic with EBITDA of $2 to $20M. It provides financing for growth equity investments, corporate divestitures and recapitalizations.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by EAG Laboratories. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of EAG Laboratories's profile does not indicate a business or promotional relationship of any kind between RelSci and EAG Laboratories.